000			01338 a2200205 4500
003			OSt
005			20251211111540.0
008			251211b |||||||| |||| 00| 0 eng d
040			_aAIKTC-KRRC _cAIKTC-KRRC
100			_aBubna, Aditya Kumar _925424
245			_aImiquimod - Its role in the treatment of cutaneous malignancies
250			_aVol.47(4), Jul-Aug
260			_aMumbai _bWolter Kluwer _c2015
300			_a354-359p.
520			_aImiquimod is a synthetic imidazoquinolone amine, which has potent immune response modifier activity, when topically used. This characteristic property of imiquimod has led to its use in a number of applications in dermatology, particularly in cutaneous malignancies, where it has been found to be effective and safe. Currently, additional mechanisms for its activity in actinic keratosis, basal cell carcinoma, and invasive squamous cell carcinoma have been elucidated. Its usage for cutaneous metastasis in breast cancer has been a further addition to its therapeutic armamentarium recently.
650		0	_aPHARMACOLOGY _94774
773	0		_x0253-7613 _tIndian Journal of Pharmacology _dAndheri - Mumbai Wolters Kluwer India Private Limited
856			_uhttps://journals.lww.com/iphr/fulltext/2015/47040/imiquimod___its_role_in_the_treatment_of_cutaneous.3.aspx _yClick here
942			_2ddc _cAR
999			_c23775 _d23775